Literature DB >> 9790979

Posttranslational modification of glycosylphosphatidylinositol (GPI)-specific phospholipase D and its activity in cleavage of GPI anchors.

H Tsujioka1, Y Misumi, N Takami, Y Ikehara, H Tujioka.   

Abstract

Human glycosylphosphatidylinositol-specific phospholipase D (GPI-PLD) was exogenously expressed in mammalian CHO cells and in insect H5 cells. GPI-PLD was initially synthesized as a 105-kDa form and then secreted as a mature 115-kDa form from the CHO cells, whereas it was secreted as an immature 98-kDa form from the H5 cells. The difference of the molecular forms was caused by its oligosaccharide processing in the two cell lines. These forms showed a different reactivity to anti-C-terminal peptide of GPI-PLD; the 105-kDa and 98-kDa forms were directly recognized by the antibodies, whereas the 115-kDa form was immunoreactive only after being denatured. In an in vitro assay, the 98-kDa form but not the 115-kDa form was able to release a significant amount of GPI-anchored proteins from intact membranes, although the two forms had the same GPI-anchor cleavage activity in the presence of detergents. In addition, a GPI-anchored protein, when coexpressed in CHO cells, was intracellularly cleaved by GPI-PLD in the secretory pathway. Taken together, these results suggest that GPI-PLD undergoes a conformational change by posttranslational modification, which affects its immunoreactive and enzymatic properties. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9790979     DOI: 10.1006/bbrc.1998.9542

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Intracellular cleavage of glycosylphosphatidylinositol by phospholipase D induces activation of protein kinase Calpha.

Authors:  H Tsujioka; N Takami; Y Misumi; Y Ikehara
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

2.  Tolerance of glycosylphosphatidylinositol (GPI)-specific phospholipase D overexpression by Chinese hamster ovary cell mutants with aberrant GPI biosynthesis.

Authors:  Xiaohan Du; Jiewei Cai; Jian-zhong Zhou; Victoria L Stevens; Martin G Low
Journal:  Biochem J       Date:  2002-01-01       Impact factor: 3.857

3.  Down-regulation of glycosylphosphatidylinositol-specific phospholipase D induced by lipopolysaccharide and oxidative stress in the murine monocyte- macrophage cell line RAW 264.7.

Authors:  X Du; M G Low
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

4.  GDE2 promotes neurogenesis by glycosylphosphatidylinositol-anchor cleavage of RECK.

Authors:  Sungjin Park; Changhee Lee; Priyanka Sabharwal; Mei Zhang; Caren L Freel Meyers; Shanthini Sockanathan
Journal:  Science       Date:  2013-01-18       Impact factor: 47.728

5.  GPI-specific phospholipase D mRNA expression in tumor cells of different malignancy.

Authors:  H Xiaotong; Melanie-Jane Hannocks; Ian Hampson; Georg Brunner
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

6.  Effect of glycosylphosphatidylinositol (GPI)-phospholipase D overexpression on GPI metabolism.

Authors:  Karl J Mann; Matthew R Hepworth; Nandita S Raikwar; Mark A Deeg; Daniel Sevlever
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

7.  Angiotensin-converting enzyme is a GPI-anchored protein releasing factor crucial for fertilization.

Authors:  Gen Kondoh; Hiromasa Tojo; Yuka Nakatani; Nobuyasu Komazawa; Chie Murata; Kazuo Yamagata; Yusuke Maeda; Taroh Kinoshita; Masaru Okabe; Ryo Taguchi; Junji Takeda
Journal:  Nat Med       Date:  2005-01-23       Impact factor: 53.440

Review 8.  Biosynthesis and biology of mammalian GPI-anchored proteins.

Authors:  Taroh Kinoshita
Journal:  Open Biol       Date:  2020-03-11       Impact factor: 6.411

9.  Interaction of Full-Length Glycosylphosphatidylinositol-Anchored Proteins with Serum Proteins and Their Translocation to Cells In Vitro Depend on the (Pre-)Diabetic State in Rats and Humans.

Authors:  Günter A Müller; Andreas Lechner; Matthias H Tschöp; Timo D Müller
Journal:  Biomedicines       Date:  2021-03-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.